Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains

Infection and Immunity

Volumn 66, Issue 5, 1998, Pages 2213-2220

  Bohn, Erwin ^a   Schmitt, Edgar ^b   Bielfeldt, Claudia ^a   Noll, Annette ^a   Schulte, Ralf ^a   Autenrieth, Ingo B ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; PROTEIN P55; RECOMBINANT INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BACTERIAL IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOMODULATION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; YERSINIA ENTEROCOLITICA;

EID: 0031948844     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.5.2213-2220.1998     Document Type: Article

References (46)

1. Autenrieth, I. B., M. Beer, E. Bohn, S. H. E. Kaufmann, and J. Heesemann. 1994. Immune respouses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect. Immun. 62:2590-2599.
2. Autenrieth, I. B., M. Beer, P. Hantschmann, S. Preger, U. Vogel, B. Heymer, and J. Heesemann. 1993. The cellular immune response against Yersinia enterocolitica in different inbred strains of mice: evidence for an important role of T lymphocytes. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 278:383-395.
3. Autenrieth, I. B., E. Bohn, J. H. Ewald, and J. Heesemann. 1995. Deferoxamine B but not deteroxamine G1 inhibits cytokine production in murine bone marrow macrophages. J. Infect. Dis. 172:490-496.
4. Autenrieth, I. B., and J. Heesemann. 1992. In vivo neutralization of tumor necrosis factor alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica in mice. Med. Microbiol. Immunol. 181:333-338.
5. Autenrieth, I. B., U. Vogel, S. Preger, B. Heymer, and J. Heesemann. 1993. Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect. Immun. 61:2585-2595.
6. Barral, A., M. Barral Netto, E. C. Yong, C. E. Brownell, D. R. Twardzik, and S. G. Reed. 1993. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 90:3442-3446.
7. Barral Netto, M., A. Barral, C. E. Brownell, Y. A. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257:545-548.
8. Bohn, E., and I. B. Autenrieth. 1998. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J. Immunol. 156:1458-1468.
9. Bouza, E., A. Dominguez, M. Meseguer, L. Buzon, D. Boixeda, M. J. Revillo, L. de Rafael, and J. Martinez Beltran. 1980. Yersinia entercolitica septicemia. Am. J. Clim. Pathol. 74:404-409.
10. Dalton, D. K., S. Pitts Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
11. Denis, M., and E. Gihadirian. 1991. Transforming growth factor beta (TGF-β1) plays a detrimental role in the progression of experimental Mycobacterium avium infection: in vivo and in vitro evidence. Microb. Pathog. 11:367-372.
12. Espevik, T., I. S. Figari, M. R. Shalaby, G. A. Lackides, G. D. Lewis, H. M. Shepard, and M. A. Palladino. 1987. Inhibition of cytokine produetion by cyclosporin A and transforming growth factor beta. J. Exp. Med. 166:571-576.
13. Fargeas, C., C. Y. Wu, T. Nakajima, D. Cox, T. Nutman, and G. Delespesse. 1992. Differential effect of transforming growth factor beta on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 22:2173-2176.
14. Gately, M. K., R. R. Warrier, S. Honasoge, D. M. Carvajal, D. A. Faherty, S. E. Connaughton, T. D. Anderson, U. Sarmiento, B. R. Hubbard, and M. Murphy. 1994. Administration of recombinant IL.-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int. Immunol. 6:157-167.
15. Goding, J. W. 1986. Monoclonal antibodies: principle and practice, p. 262-265. Academic Press, Inc., London, United Kingdom.
16. Hancock, C. E., R. W. Schacdler, and T. T. MacDonald. 1996 Yersinia enterocolitica infection in resistant and susceptible strains of mice. Infect. Immun. 53:26-31.
17. Hanski, C., U. Kutschka, H. P. Schmoranzer, M. Naumann, A. Stallmach, H. Hahn, H. Menge, and E. O. Rietken. 1999. Immunohistoehemical and electron microscopic study of intcraction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect. Immun. 57:673-678.
18. Heiniel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon-gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 169:59-72.
19. Hoehn, P., S. Goedert, T. Germann, S. Koelsch, S. Jin, N. Palm, E. Ruede, and E. Schmitt. 1995. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains. J. Immunol. 155:3788-3793.
20. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response m mice that lack the interferon-gamma receptor. Science 259:1742-1745.
21. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington. 1995. Transforming growth factor-beta inhibits interleukin-12-induuced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in lhc regulation of T cell-independent resistence to Toxoplasma gondii. Eur. J. Immunol. 25:994-1000.
22. Kamijo, R., J. Le, D. Shapiro, E. A. Havell, S. Huang, M. Aguet, M. Bosland, and J. Vilcek. 1993. Mice that lack the interfcron-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178:1435-1440.
23. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-1050.
24. Lian, C. J., W. S. Hwang, and C. H. Pai. 1987. Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect. Immun. 55:1176-1183.
25. Matsumoto, M., Y. X. Fu, H. Molina, and D. D. Chaplin. 1997 Lymphotoxinalpha-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137-144.
26. Morris, L., T. Aebischer, E. Handman, and A. Kelso. 1993. Resistance of BALB/c mice to Leishmania major infection is associated with a decrease in the precursor frequency of antigen-specific CD4+ cells secreting interleukin-4. Int. Immunol. 5:761-767.
27. - T cells. Infect. Immun. 61:3730-3738.
28. Nagelkerken, L., K. J. Gollob, M. Tielemans, and R. L. Coffman. 1993. Role of transforming growth factor-beta in the preferential induction of T helper cells of type 1 by staphylococcal enlcroloxin B. Eur. J. Immunol. 23:2306-2310.
29. Nakane, A., M. Asano, S. Sasaki, S. Nishikawa, T. Miura, M. Kohanawa, and T. Minagawa. 1996. Transforming growth factor beta is protective in host resistance against Listeria mnocytogenes infection in mice. Infect. Immun. 64:3901-3904.
30. Nelson, B. J., P. Ralph, S. J. Green, and C. A. Nacy. 1991. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J. Immunol. 146: 1849-1857.
31. Orange, J. S., T. P. Salazar Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. MeEwen, and C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901-914.
32. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253-1264.
33. Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, and G. Garotta. 1994. Interleukin 12, Interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180:907-915.
34. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegniann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 Kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
35. Powrie, F. 1995. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3:171-174.
36. Rabson, A. R., A. F. Hallett, and H. J. Koornhof. 1975. Generalized Yersinia enterocolitica infection. J. Infect. Dis. 131:447-451.
37. Ranges, G. E., I. S. Figari, T. Espevik, and M. A. Palladino. 1987. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 166:991-998.
38. Rook, A. H., J. H. Kehrl, L. M. Wakefield, A. B. Roberts, M. B. Sporn, D. B. Burlington, H. C. Lane, and A. S. Fauci. 1986. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136:3916-3920.
39. Silva, J. S., D. R. Twardzik, and S. G. Reed. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J. Exp. Med. 174:539-545.
40. Simonet, M., S. Richard, and P. Berche. 1990. Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotberculosis harboring the pYV plasmid. Infect. Immun. 58:841-845.
41. Spaccapelo, R., L. Romani, L. Tonnetti, E. Cenci, A. Mencacci, G. Del Sero, R. Tognellini, S. G. Reed, P. Puccetti, and F. Bistoni. 1995. TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol. 155:1349-1360.
42. Stenger. S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inclucible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
43. Swain, S. L., G. Huston, S. Tonkonogy, and A. Weinberg. 1991. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:2991-3000.
44. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL-)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817-824.
45. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor-beta. Nature 334:260-262.
46. Wu, C. Y., C. E. Demeure, M. Gately, F. Podlaski, H. Yssel, M. Kiniwa, and G. Delespesse. 1994. In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 152:1141-1153.